Lunai Bioworks, Inc. — Form 8-K Summary
Reporting date: October 9, 2026. The report concerns a request to Nasdaq regarding trading in the company’s common stock, not a financial-results announcement.
Business context and financial information
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial metrics. It provides no comparable-period financial data.
Material event
On October 9, 2026, Lunai asked Nasdaq to immediately suspend trading in its common stock while Nasdaq, FINRA, and other authorities review trading records. The company says records obtained through court-ordered discovery raise concerns about substantial short selling, locate deficiencies, concentrated failures to deliver, and other activity that may call into question whether the market was fair and orderly.
The records relate to the company’s pending lawsuit, Lunai Bioworks, Inc. v. Seven Points Capital LLC et al., Case No. 1:26-cv-00549-CFC, in the U.S. District Court for the District of Delaware. The company’s allegations have not been adjudicated. As of the filing, Nasdaq had not decided on the request. The request itself does not halt trading; any suspension or other protective action is Nasdaq’s decision. The company says it cannot predict whether or when Nasdaq will respond and intends to continue the litigation and related investigation.
Outlook, risks, and contingencies
The filing provides no financial guidance or business outlook. Key uncertainties include whether Nasdaq or a regulatory authority will act, whether trading will be suspended, and the outcome of the pending litigation. The company cautions that forward-looking statements are subject to risks and actual results may differ materially.
Investor verification points
- Check Nasdaq notices for any decision on Lunai’s suspension request and the status of trading.
- Review court filings and subsequent developments in the pending litigation; the company’s allegations remain unresolved.
- Look for later company disclosures or regulatory updates concerning the trading records and related investigation.